Dose Regimen Study of SLI-F06 in Healthy Volunteers
NCT05501327
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar appearance
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Scar
- Wound Healing
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Scarless Laboratories, Inc.
- Last updated on ClinicalTrials.gov
- July 27, 2023
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- California Dermatology & Clinical Research Institute · Encinitas, CA
Texas · 1
- DermResearch · Austin, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.